1887
  1. Home
  2. Eurosurveillance
  3. Volume 31, Issue 22, 04/Jun/2026
  4. Article
Research Open Access
Like 0
Download

Abstract

BACKGROUND

With a notification rate of 44.9 per million population in 2024, Belgium was among the countries with the highest measles rate of the European Union/European Economic Area countries. Although the coverage of the first dose of measles–mumps–rubella (MMR) vaccination in Flanders was 96% in 2020, two-dose coverage was below 95%. To minimise the risk of sustained measles transmission in vulnerable settings, such as primary schools with low vaccination coverage or daycares, it is important to quarantine susceptible contacts of a measles case.

AIM

We aimed to identify policies that balance measles outbreak control with societal as well as educational impact of quarantining children.

METHODS

Using a simulation model, we evaluated the impact of different quarantine strategies for measles in primary school and daycare settings in Flanders, Belgium.

RESULTS

We found that shortening the quarantine period from 21 to 18 days only moderately (e.g. 16–37% in primary school) increased the risk of a subsequent infection wave, and the final proportion of later-generation cases remained at most 3.2% of the school or daycare. In settings with a low vaccination coverage (e.g. 20%), multiple independent introductions or a low diagnosis rate (e.g. only half of symptomatic children going to a doctor), the addition of post-exposure vaccination can further reduce transmission risk.

CONCLUSION

We found that quarantine duration could be shorter than the presumed maximal incubation period of 21 days, without substantially increasing the risk of onward transmission. As such, acceptability and compliance with mandated quarantine periods might also increase.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2026.31.22.2500763
2026-06-04
2026-07-18
/content/10.2807/1560-7917.ES.2026.31.22.2500763
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/31/22/eurosurv-31-22-4.html?itemId=/content/10.2807/1560-7917.ES.2026.31.22.2500763&mimeType=html&fmt=ahah

References

  1. Minta AA, Ferrari M, Antoni S, Lambert B, Sayi TS, Hsu CH, et al. Progress towards measles elimination – worldwide, 2000-2023. MMWR Morb Mortal Wkly Rep. 2024;73(45):1036-42.  https://doi.org/10.15585/mmwr.mm7345a4  PMID: 39541251 
  2. World Health Organization (WHO). 9th Meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC). Geneva: WHO; 30 Nov 2021. Available from: https://www.who.int/europe/publications/i/item/WHO-EURO-2021-4369-44132-62279
  3. European Centre for Disease Prevention and Control (ECDC). Measles — Annual Epidemiological Report for 2024. Stockholm: ECDC; 28 Apr 2025. Available from: https://www.ecdc.europa.eu/en/publications-data/measles-annual-epidemiological-report-2024
  4. Kuylen E, Willem L, Broeckhove J, Beutels P, Hens N. Clustering of susceptible individuals within households can drive measles outbreaks: an individual-based model exploration. Sci Rep. 2020;10(1):19645.  https://doi.org/10.1038/s41598-020-76746-3  PMID: 33184409 
  5. Grammens T, Cornelissen L. Vaccinatiegraad van basisvaccinaties. [Vaccination coverage of the basic vaccinations]. Brussels: Sciensano; 2021. Flemish. Available from: https://www.sciensano.be/nl/biblio/vaccinatiegraad-van-basisvaccinaties
  6. Pattyn J, Hanning N, Valckx S, Claessens T, Karafillakis E, Jong V, et al. Investigating the state of vaccine confidence among the general public and parents with children up to 13 years in Flanders (Belgium). Vaccine. 2025;58:127250.  https://doi.org/10.1016/j.vaccine.2025.127250  PMID: 40378551 
  7. Braeye T, Sabbe M, Hutse V, Flipse W, Godderis L, Top G. Obstacles in measles elimination: an in-depth description of a measles outbreak in Ghent, Belgium, spring 2011. Arch Public Health. 2013;71(1):17.  https://doi.org/10.1186/0778-7367-71-17  PMID: 23834074 
  8. Asnong C, Van Herck K, Lernout T, Theeten H, Van Damme P. Lessons learned from a measles outbreak in Antwerp, Belgium 2007-2008. Pediatr Infect Dis J. 2011;30(4):343-5.  https://doi.org/10.1097/INF.0b013e3181fbf5b7  PMID: 20924311 
  9. Schenk J, Abrams S, Litzroth A, Cornelissen L, Grammens T, Theeten H, et al. Identifying immunity gaps for measles using Belgian serial serology data. Vaccine. 2022;40(26):3676-83.  https://doi.org/10.1016/j.vaccine.2022.05.009  PMID: 35589453 
  10. Enanoria WT, Liu F, Zipprich J, Harriman K, Ackley S, Blumberg S, et al. The effect of contact investigations and public health interventions in the control and prevention of measles transmission: a simulation study. PLoS One. 2016;11(12):e0167160.  https://doi.org/10.1371/journal.pone.0167160  PMID: 27941976 
  11. Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DA. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis. 2009;9(5):291-300.  https://doi.org/10.1016/S1473-3099(09)70069-6  PMID: 19393959 
  12. Gastañaduy PA, Banerjee E, DeBolt C, Bravo-Alcántara P, Samad SA, Pastor D, et al. Public health responses during measles outbreaks in elimination settings: Strategies and challenges. Hum Vaccin Immunother. 2018;14(9):2222-38.  https://doi.org/10.1080/21645515.2018.1474310  PMID: 29932850 
  13. Centers for Disease Control and Prevention (CDC). Chapter 13: measles. In: The Pink Book. 14th ed. Atlanta: CDC; Aug 2021. Available from: https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
  14. Bianchi FP, Mascipinto S, Stefanizzi P, De Nitto S, Germinario C, Tafuri S. Long-term immunogenicity after measles vaccine vs. wild infection: an Italian retrospective cohort study. Hum Vaccin Immunother. 2021;17(7):2078-84.  https://doi.org/10.1080/21645515.2020.1871296  PMID: 33502929 
  15. Khampanisong P, Pauly M, Nouanthong P, Vickers MA, Virachith S, Xaydalasouk K, et al. Waning of maternal antibodies against measles suggests a large window of susceptibility in infants in Lao People’s Democratic Republic. Pathogens. 2021;10(10):1316.  https://doi.org/10.3390/pathogens10101316  PMID: 34684265 
  16. Hens N, Abrams S, Santermans E, Theeten H, Goeyvaerts N, Lernout T, et al. Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013. Euro Surveill. 2015;20(1):20998.  https://doi.org/10.2807/1560-7917.ES2015.20.1.20998  PMID: 25613653 
  17. Hoang T, Coletti P, Melegaro A, Wallinga J, Grijalva CG, Edmunds JW, et al. A systematic review of social contact surveys to inform transmission models of close-contact infections. Epidemiology. 2019;30(5):723-36.  https://doi.org/10.1097/EDE.0000000000001047  PMID: 31274572 
  18. Torneri A, Willem L, Colizza V, Kremer C, Meuris C, Darcis G, et al. Controlling SARS-CoV-2 in schools using repetitive testing strategies. eLife. 2022;11:e75593.  https://doi.org/10.7554/eLife.75593  PMID: 35787310 
  19. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005;438(7066):355-9.  https://doi.org/10.1038/nature04153  PMID: 16292310 
  20. Pike J, Melnick A, Gastañaduy PA, Kay M, Harbison J, Leidner AJ, et al. Societal costs of a measles outbreak. Pediatrics. 2021;147(4):e2020027037.  https://doi.org/10.1542/peds.2020-027037  PMID: 33712549 
  21. Mizumoto K, Kobayashi T, Chowell G. Transmission potential of modified measles during an outbreak, Japan, March‒May 2018. Euro Surveill. 2018;23(24):1800239.  https://doi.org/10.2807/1560-7917.ES.2018.23.24.1800239  PMID: 29921344 
  22. Marziano V, Bella A, Menegale F, Del Manso M, Petrone D, Palamara AT, et al. Estimating measles susceptibility and transmission patterns in Italy: an epidemiological assessment. Lancet Infect Dis. 2025;25(12):1303-13.  https://doi.org/10.1016/S1473-3099(25)00293-2  PMID: 40753987 
  23. Braeye T, Sabbe M, Hutse V, Flipse W, Godderis L, Top G. Obstacles in measles elimination: an in-depth description of a measles outbreak in Ghent, Belgium, spring 2011. Arch Public Health. 2013;71(1):17.  https://doi.org/10.1186/0778-7367-71-17  PMID: 23834074 
  24. Bonačić Marinović AA, Swaan C, Wichmann O, van Steenbergen J, Kretzschmar M. Effectiveness and timing of vaccination during school measles outbreak. Emerg Infect Dis. 2012;18(9):1405-13.  https://doi.org/10.3201/eid1809.111578  PMID: 22931850 
Informing quarantine policy for measles control in primary school and daycare settings: insights from a simulation study, Flanders, Belgium
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=C%C3%A9cile+Kremer&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Kremer Cécile</a>, <a href="/search?value1=Na%C3%AFma+Hammami&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hammami Naïma</a>, <a href="/search?value1=Laura+Cornelissen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Cornelissen Laura</a>, <a href="/search?value1=Heidi+Theeten&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Theeten Heidi</a>, <a href="/search?value1=Toon+Braeye&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Braeye Toon</a>, <a href="/search?value1=Andrea+Torneri&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Torneri Andrea</a>, <a href="/search?value1=Steven+Abrams&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Abrams Steven</a>, <a href="/search?value1=Niel+Hens&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hens Niel</a></span>. Informing quarantine policy for measles control in primary school and daycare settings: insights from a simulation study, Flanders, Belgium. <a href="/content/ecdc">Euro Surveill.</a> 2026;31(22):pii=2500763. <a href="https://doi.org/10.2807/1560-7917.ES.2026.31.22.2500763" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2026.31.22.2500763</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 01 Oct 2025;&nbsp;&nbsp; <span class="generated">Accepted</span>: 09 Feb 2026 </span> </p>
/content/10.2807/1560-7917.ES.2026.31.22.2500763
/content/10.2807/1560-7917.ES.2026.31.22.2500763
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error